BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1582812)

  • 1. Progressive color visual field loss in glaucoma.
    Sample PA; Weinreb RN
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):2068-71. PubMed ID: 1582812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color perimetry for assessment of primary open-angle glaucoma.
    Sample PA; Weinreb RN
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1869-75. PubMed ID: 2211033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucomatous visual field damage. Luminance and color-contrast sensitivities.
    Hart WM; Silverman SE; Trick GL; Nesher R; Gordon MO
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):359-67. PubMed ID: 2303333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foveal and non-foveal measures of short wavelength sensitive pathways in glaucoma and ocular hypertension.
    Heron G; Adams AJ; Husted R
    Ophthalmic Physiol Opt; 1987; 7(4):403-4. PubMed ID: 3454916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of central visual field in end-stage glaucoma.
    Much JW; Liu C; Piltz-Seymour JR
    Ophthalmology; 2008 Jul; 115(7):1162-6. PubMed ID: 18067965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased threshold for detection of phase differences in pattern-induced color flicker fusion in patients with glaucoma].
    Tritsch MF; Pfeiffer N
    Klin Monbl Augenheilkd; 1994 Jul; 205(1):27-32. PubMed ID: 7933905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characteristics of blue-on-yellow perimetric thresholds in glaucoma.
    Felius J; de Jong LA; van den Berg TJ; Greve EL
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1665-74. PubMed ID: 7601646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color vision deficit in normal-tension glaucoma eyes.
    Yamagami J; Koseki N; Araie M
    Jpn J Ophthalmol; 1995; 39(4):384-9. PubMed ID: 8926646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central visual fields for short wavelength sensitive pathways in glaucoma and ocular hypertension.
    Heron G; Adams AJ; Husted R
    Invest Ophthalmol Vis Sci; 1988 Jan; 29(1):64-72. PubMed ID: 3335434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red-green chromatic mechanisms in normal aging and glaucomatous observers.
    Karwatsky P; Overbury O; Faubert J
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2861-6. PubMed ID: 15277514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse field loss and central visual function in glaucoma.
    Lachenmayr BJ; Drance SM
    Ger J Ophthalmol; 1992; 1(2):67-73. PubMed ID: 1477628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Threshold testing of the macular area in glaucoma].
    Capoferri C; Garavaglia A; Buscemi M; Nassivera C; Brancato R
    J Fr Ophtalmol; 1989; 12(10):709-14. PubMed ID: 2638372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interocular asymmetry of visual field defects in primary open angle glaucoma and primary angle-closure glaucoma.
    Wang JC; Gazzard G; Foster PJ; Devereux JG; Oen FT; Chew PT; Khaw PT; Seah SK
    Eye (Lond); 2004 Apr; 18(4):365-8. PubMed ID: 15069431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma.
    Teesalu P; Airaksinen PJ; Tuulonen A
    Ophthalmology; 1998 Nov; 105(11):2077-81. PubMed ID: 9818609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.